With the COVID-19 vaccination rate of adults receiving at least one dose now topping 60 percent in the U.S., and the Centers for Disease Control and Prevention (CDC) easing mask guidelines for those who have been vaccinated, recent grocery/CPG shopping data from shopper intelligence leader Catalina underscores the increasing enthusiasm for returning to a sense of normalcy sweeping the country after 15 months of varying degrees of restrictions. Continue reading
A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released the 1st edition of its report titled “COVID-19 Vaccines – Global Market Trajectory & Analytics”. The report presents fresh perspectives on what to expect post commercialization of COVID-19 vaccines amid the rising spirit of vaccine nationalism, selfish international politics over vaccines, inadequate market access, stockpiling, and vaccine patents that still remain firmly in place. Continue reading
AXON Neuroscience (“Axon”), a clinical-stage biotech company and an industry leader in treating and preventing neurodegenerative diseases with a unique peptide vaccine platform, is launching the world’s first independently-developed crowdfunded vaccine against COVID-19 – ACvac1. Read more
The Massachusetts Institute of Technology has developed a drug delivery method that packs multiple doses in a single injection, and could soon make multi-shot vaccines a thing of the past. Continue reading
REUTERS/ MEDECINS SANS FRONTIERES HANDOUT/ WORLD HEALTH ORGANIZATION) – It may soon be possible to protect humans against the deadly Ebola virus.
A new vaccine being tested in Guinea has been 100-percent effective,
Early tests of experimental vaccine triggers the production of Ebola virus neutralizing antibodies, researchers say.
(Next Media Online) – Following the February 23 death of a German toddler from measles, health officials in Berlin are considering making vaccinations mandatory.